Answers are grounded in this paper and cite their sources.
The aim of this paper is to draw up-to-date conclusions regarding small cell neuroendocrine carcinoma (SCC) of the parotid gland reviewing the largest case series from the literature and presenting them in a chronicle type manner. In addition, the first Greek case of SCC of the parotid gland with a favorable outcome is being reported. A case occurred in a 76-year-old male patient is presented here. A partial parotidectomy and a selective neck dissection were performed. Post-operatively he underwent radiotherapy. A clinical and radiological follow-up examination disclosed no complication or recurrence until now, 5 years after surgery. The immunohistochemical study demonstrated that the tumor cells were positive for cytokeratin 20 (CK 20) among others neuroendocrine markers. SCC of the parotid gland is a rare and very aggressive malignancy with histologic and immunostaining overlap with others SCCs. Clinicopathologic and demographic characteristics of this entity are very well defined. Prognosis remain very poor. Prognosticators that have been proved to reduce overall survival are tumor size and older age. Prospective studies are needed to establish better treatment modalities. Until then, treatment plan should be aggressive and encompass extended excision with neck dissection and adjuvant radiotherapy or chemoradiotherapy.
No takes yet. Share an insight, caveat, or question.
Ioannis et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: